Lymphoma Working Party (LWP)
Study type:
Study number:
84032215
Type of treatment:
Allogeneic
Diseases:
Non-Hodgkin’s Lymphoma (NHL)
Short title:
SCT IN INDOLENT NHL
Primary objective:
1. Benchmark study: updated outcome of stem cell transplant for FL and MZL across EBMT centres
2.Report the current expected outcome with standard of care as a comparator for studies on new
therapies.
2.Report the current expected outcome with standard of care as a comparator for studies on new
therapies.
Key inclusion criteria:
1. Age >= 18 years at time of transplant
2. Diagnosis of
- 250 follicular lymphoma
- 230 Nodal marginal zone lymphoma
- 210 splenic marginal zone lymphoma
- 220 Extranodal marginal zone lymphoma of mucosa associated lymphoid tissue (MALT)
3. Reported in the EBMT registry for
- 1st Autologous SCT
- 1st Allogeneic stem cell transplant
4. Stem cell transplant performed between 2010 and 2022
2. Diagnosis of
- 250 follicular lymphoma
- 230 Nodal marginal zone lymphoma
- 210 splenic marginal zone lymphoma
- 220 Extranodal marginal zone lymphoma of mucosa associated lymphoid tissue (MALT)
3. Reported in the EBMT registry for
- 1st Autologous SCT
- 1st Allogeneic stem cell transplant
4. Stem cell transplant performed between 2010 and 2022
Country:
All EBMT member countries
Principal investigator:
Yasmina Serroukh
EBMT Study coordinator:
Irma Khvedelidze
Study coordinator email:
irma.khvedelidze@ebmt.org
EBMT Study Unit:
Paris Study Unit
Reason for processing personal data:
Research and Development of new and improved transplant, cell therapy and immunosuppression procedures.
Categories of personal data collected:
Medical data already reported to the EBMT Registry
Recipients who may access the data:
Paris Study Unit
3rd-party processors of Personal Data on behalf of EBMT/Service provider:
No
Privacy notices
Article 6 lawful basis for processing personal data:
Article 6.1 (a) - Consent (Collection)
Article 9 basis for processing special category data:
Article 9(2) (a) - Consent (Collection)
Data Protection Impact Assessments
Rights available to individuals:
Access
Data portability
Rectification
Objection
Deletion
Is a Data Protection Impact Assessment required?:
DPIA performed for EBMT Registry (WP & NIS Studies)
Retention Schedule (if possible):
at least 5 years after the final report or first publication of study results